HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preliminary results of the Nottingham breast self-examination education programme.

Abstract
Between June 1979 and December 1984, 49,573 women (study population) between the ages of 45 and 64 years and living in one health district were invited to attend breast self-examination sessions as part of the DHSS 'UK Trial of Early Detection of Breast Cancer'. Of the women invited 50.2 per cent attended for education. A total of 319 breast cancers were diagnosed in the study population during this period. The tumour characteristics, patient prognostic groups and survival have been compared with a control population consisting of the 319 consecutive breast cancers diagnosed immediately before the start of the DHSS trial, in women of the same age group and living in the same health district. There has been a significant reduction in the size at presentation of operable tumours (P less than 0.01) and there has been a small (3.4 per cent) reduction in lymph node involvement, but this is not significant. The rates of presentation of both in situ and advanced carcinoma have not significantly changed following the introduction of a breast self-examination education programme. At this stage no overall survival difference has been identified between the two groups but the median follow up of the study population is limited (25 months).
AuthorsC S Dowle, A Mitchell, C W Elston, E J Roebuck, C P Hinton, H Holliday, R W Blamey
JournalThe British journal of surgery (Br J Surg) Vol. 74 Issue 3 Pg. 217-9 (Mar 1987) ISSN: 0007-1323 [Print] England
PMID3567517 (Publication Type: Journal Article)
Topics
  • Breast
  • Breast Neoplasms (mortality, pathology, prevention & control)
  • Female
  • Health Education
  • Humans
  • Lymphatic Metastasis
  • Mammography
  • Mass Screening (methods)
  • Middle Aged
  • Palpation
  • Prognosis
  • Retrospective Studies
  • United Kingdom

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: